Marrow signal changes observed in follow-up whole-body MRI studies in children and young adults with neurofibromatosis type 1 treated with imatinib mesylate (Gleevec) for plexiform neurofibromas

Author: Karmazyn Boaz   Cohen Mervyn   Jennings Samuel   Robertson Kent  

Publisher: Springer Publishing Company

ISSN: 0301-0449

Source: Pediatric Radiology, Vol.42, Iss.10, 2012-10, pp. : 1218-1222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next